Bio-Thera and STADA Expand Alliance with Biosimilars-Tocilizumab
August 22, 2025 — Bio-Thera Solutions and STADA Arzneimittel have announced the expansion of their biosimilars partnership to include...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
August 22, 2025 — Bio-Thera Solutions and STADA Arzneimittel have announced the expansion of their biosimilars partnership to include...
August 21, 2025: The U.S. Food and Drug Administration (FDA) has issued a public health advisory cautioning against consumption,...
ANKARA, Türkiye, August 18, 2025 — SmartAlpha’s AI-powered software, Nerveblox, designed to assist clinicians performing ultrasound-guided regional anesthesia (“nerve...
